- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05904990
High-intensity Laser Therapy Improves Pain, Health Status and Quality of Life in Women With Fibromyalgia
March 16, 2024 updated by: Kerolous Ishak Shehata, October 6 University
High-intensity Laser Therapy Improves Pain, Health Status and Quality of Life in Women With Fibromyalgia: A Single Blinded-randomized Controlled Trial
This study will be conducted to investigate High-intensity laser therapy improves pain, health status and quality of life in women with fibromyalgia
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Giza, Egypt
- Kerolous ishak shehata kelini
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- WPI ≥ 7/19 pain sites and SSS ≥ 5/12 or WPI between > 3-6/19 and SSS > 9/12
- symptoms have been present at a similar level for at least 3 months
- the patient does not have another disorder that would otherwise sufficiently explain the pain
- generalized pain, defined as pain in at least four of five regions, is present
Exclusion Criteria:
- uncontrolled diabetes
- known history of cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: traditional exercise therapy only
This 50-minute program included a 10-minute warm-up phase (treadmill walking at a comfortable speed), 30 minutes of stretching exercises for (glutei, paraspinal muscles, hamstring, pectoralis, scalenus, intercostal muscles, and trapezius), and a 10-minute cool-down involving self-stretching and respiratory exercises.
|
50-minute program included a 10-minute warm-up phase (treadmill walking at a comfortable speed), 30 minutes of stretching exercises for (glutei, paraspinal muscles, hamstring, pectoralis, scalenus, intercostal muscles, and trapezius), and a 10-minute cool-down involving self-stretching and respiratory exercises
|
|
Experimental: HILT alongside traditional exercise therapy,
pulsed Nd: YAG laser device (HIRO 3.0; ASA Laser, Arcugnano, Italy).
This equipment delivers pulsed laser light at a wavelength of 1,064 nm, with a very high peak power of 3 kW and energy density ranging from 360 to 1,780 mJ/cm2.
|
50-minute program included a 10-minute warm-up phase (treadmill walking at a comfortable speed), 30 minutes of stretching exercises for (glutei, paraspinal muscles, hamstring, pectoralis, scalenus, intercostal muscles, and trapezius), and a 10-minute cool-down involving self-stretching and respiratory exercises
YAG laser device (HIRO 3.0; ASA Laser, Arcugnano, Italy).
This equipment delivers pulsed laser light at a wavelength of 1,064 nm, with a very high peak power of 3 kW and energy density ranging from 360 to 1,780 mJ/cm2.
It operates with short pulse durations between 120 and 150 μs, at low frequencies of 10 to 40 Hz, and has a duty cycle of about 0.1%.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Revised Fibromyalgia Impact Questionnaire (FIQR)
Time Frame: up to 6 weeks
|
assesses the overall severity of FM and health status based on participant ratings.
It encompasses three key domains similar to the FIQ (function, overall impact, and symptoms), with additional inquiries regarding memory, tenderness, balance, and environmental sensitivity
|
up to 6 weeks
|
|
Visual Analog Scale (VAS)
Time Frame: up to 6 weeks
|
10 cm, where patients rated their pain on a scale from 0 ("no pain") to 10 ("extremely severe pain ") over the past 3 days
|
up to 6 weeks
|
|
pressure algometer
Time Frame: up to 6 weeks
|
This tool comprises a circular rubber tip (1 cm2) and a pressure gauge for displaying readings in kilograms.
Given the rubber tip's 1 cm² area, measurements were reported in kilograms per square centimeter (kg/cm2).
The algometer has a measurement range from 0 to 10 kg, with increments of 0.1 kg.
The instrument was pressed against the skin's surface at a right angle, and the force exerted was registered on a manometer.
|
up to 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 29, 2023
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
September 1, 2023
Study Registration Dates
First Submitted
June 7, 2023
First Submitted That Met QC Criteria
June 7, 2023
First Posted (Actual)
June 15, 2023
Study Record Updates
Last Update Posted (Actual)
March 19, 2024
Last Update Submitted That Met QC Criteria
March 16, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- p.t.REC\012\004507
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on traditional exercise therapy only
-
Rafeef Hassan AsiriActive, not recruitingRotator Cuff Tendonitis | Rotator Cuff Syndrome | Shoulder Pain SyndromeSaudi Arabia
-
Colorado State UniversityUniversity of Colorado, Denver; National Institute of Diabetes and Digestive...RecruitingDepressive Disorder | Depression | Glucose Metabolism Disorders | Mood Disorders | Insulin Resistance | Hyperinsulinism | Metabolic Disease | Mental Disorder in AdolescenceUnited States
-
Cairo UniversityCompleted
-
University of FloridaBrooke Army Medical CenterCompleted
-
Hallym University Dongtan Sacred Heart HospitalActive, not recruiting
-
Cairo UniversityNot yet recruitingHemiplegic Cerebral Palsy
-
Icahn School of Medicine at Mount SinaiTerminatedChronic Pain | Knee OsteoarthritisUnited States
-
Proaxis TherapyVirginia Commonwealth University; Arcadia University; National Athletic Trainers...CompletedShoulder Impingement SyndromeUnited States
-
Taipei Medical UniversityCompletedTrismus | Head and Neck Cancers | Radiotherapy Side EffectsTaiwan
-
Cairo UniversityActive, not recruitingGenu RecurvatumEgypt